Anebulo Pharmaceuticals (ANEB)
(Delayed Data from NSDQ)
$2.12 USD
-0.11 (-4.73%)
Updated May 24, 2024 01:57 PM ET
After-Market: $2.07 -0.05 (-2.13%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
09/18/2024
Time: -- |
6/2024 | $-0.14 | 0.00% |
Earnings Summary
For their last quarter, Anebulo Pharmaceuticals (ANEB) reported earnings of -$0.06 per share, beating the Zacks Consensus Estimate of $-0.11 per share. This reflects a positive earnings surprise of 45.45%. Look out for ANEB's next earnings release expected on September 18, 2024. For the next earning release, we expect the company to report earnings of -$0.14 per share, reflecting a year-over-year decrease of 40%.
Earnings History
Price & Consensus
Zacks News for ANEB
Are Medical Stocks Lagging Exact Sciences (EXAS) This Year?
ANEB: What are Zacks experts saying now?
Zacks Private Portfolio Services